First, NAFLD patients had increased serum FFA levels, and these levels were positively correlated with parameters of MS (BMI, TG, TC and FPG), indexes of inflammation (SA, hsCRP and WBC) and markers of hepatocellular damage (ALT, AST and GGT). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.